Establishment of lymphomatous cell lines from bone marrow samples from patients with burkitt's lymphoma

Journal of the National Cancer Institute

Volumn 73, Issue 4, 1984, Pages 835-840

  Phlllp, Irene ^a,b   Phillp, Thierry ^b   Favrot, Marie ^b   Vulllaume, Michele ^a   Fontanlere, Bernard ^b   Chamard, Didier ^b   Lenolr, Gilbert M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW; BURKITT LYMPHOMA; CANCER CELL CULTURE; CHROMOSOME TRANSLOCATION; HEREDITY; HUMAN; LYMPHATIC SYSTEM; LYMPHOBLASTOID CELL LINE; RETICULOENDOTHELIAL SYSTEM;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; BONE MARROW; BURKITT LYMPHOMA; CELL LINE; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CULTURE TECHNIQUES; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE;

EID: 0021123673     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/73.4.835     Document Type: Article

References (29)

1. Nilsson K, Pontén J. Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 1975; 15:321-341.
2. Epstein MA, Barr YM. Cultivation in vitro of human lymphoblasts from Burkitt’s malignant lymphoma. Lancet 1964; 1:252-253.
3. Magrath IT, Freeman CB, Pizzo P, et al. Characterization of lymphoma-derived cell lines: Comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers. JNCI 1980; 64:477-483.
4. Philip T, Lenoir GM, Bryon PA, et al. Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br J Cancer 1982; 45:670-678.
5. Philip I, Philip T, Favrot M, Lenoir GM. Indication for bonemarrow harvesting and purging in Burkitt’s lymphoma. In: Cavalli F, ed. Second international conference on malignant lymphoma. New York: Raven Press. In press.
6. Thursby E, Bratlie A. A new method for separation of lymphocytes from blood. In: Terasaki P, ed. Histocompatibility testing. Copenhagen: Munksgaard, 1970:655-656.
7. Reedman BM, Klein G. Cellular localization of an EBV associated complement fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int J Cancer 1973; 11:499-520.
8. Bernheim A, Berger R, Lenoir GM. Cytogenetic studies on Burkitt’s lymphoma cell lines. Cancer Genet Cytogenet 1983; 8:223-229.
9. Mark-Vendel E, Philip T, Ladjadj Y, Aboulola M, Lenoir GM. Chromosomal translocation in Algerian Burkitt’s lymphoma. Lancet 1983; 1:788.
10. Lenoir GM, Preud’Homme JL, Bernheim A, Berger R. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt’s lymphoma. Nature 1982; 298:474-476.
11. Favrot MC, Philip I, Philip T, Dore JF, Lenoir GM. Possible duality in Burkitt lymphoma origin. Lancet 1984; 2:745-746.
12. Ladjadj Y, Philip T, Lenoir GM, et al. Abdominal Burkitttype lymphomas in Algeria. Br J Cancer 1984; 49:503-512.
13. Benjamin D, Magrath IT, Douglass EC, Corash LM. Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: Evidence of occult bone marrow involvement. Blood 1983; 61:1017-1019.
14. Smith SD, Wood AW, Fried P, Lowman JT. In-vitro growth of lymphoma colonies from children with non-Hodgkin’s lymphoma. Cancer 1981; 48:2612-2623.
15. Smith SD, Kisker BS, Bush L, Trueworthy BC. Utilization of a tumor cloning system assay to monitor for bone marrow involvement in children with non-Hodgkin’s lymphoma. Cancer 1984; 53:1726-1729.
16. Hamburger AW, Salmon SE. Development of a bioassay for human myeloma colony forming cells. In: Salmon SE, ed. Cloning of human tumor stem cells. New York: Liss, 1980: 23-41.
17. Von Hoff DD, Caspe J, Bradley E, et al. Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res 1980; 40:3591-3597.
18. Pollard EB, Tio F, Myers JW, Clark G, Coltman CA Jr, Von Hoff DD. Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung. Cancer Res 1981; 41:1015-1020.
19. Neumann MA, Lohr GW, Fauser A. Growth of tumor cell colonies in bone marrow cultures of patients with small cell carcinoma of the lung. Blut 1982; 45:32.
20. Walle AJ, Darzinkiewicz Z, McKenzie J, Higgins PJ, Andreeff M. Characterization by nuclear and cellular RNA and DNA content of blood and marrow cells of patients with Burkitt type leukemia. Proc Am Assoc Cancer Res 1983; C32:8.
21. Hiddeman W, Buchner T, Andreeff M, Wormann B, Melamed MR, Clarkson BD. Bone marrow biopsy instead of “marrow juice” for cell kinetic analysis (comparison of bone marrow biopsy and aspiration material). Leuk Res 1982; 6:601-612.
22. Philip T, Lenoir GM, Fraisse J, et al. EBV-positive Burkitt’s lymphoma from Algeria with a three-way rearrangement involving chromosomes 2, 8 and 9. Int J Cancer 1981; 28:417-420.
23. Magrath IT, Pizzo PA, Whang-Peng J, et al. Characterization of lymphoma-derived cell lines: Comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. JNCI 1980; 64:465-476.
24. Douglass EC, Magrath IT, Lee EC, Whang-Peng J. Cytogenetic studies in non-African Burkitt lymphoma. Blood 1980; 55:148-155.
25. Bernheim A, Berger R, Lenoir GM. Cytogenetic studies on African Burkitt’s lymphoma cell lines. Cancer Genet Cytogenet 1981; 3:307-315.
26. Smith SD, Trueworthy R, Kisker BS, Noller L, Lowman J. In-vitro sensitivity of normal granulocytic and lymphoma colonies to tissue alkaloids. Cancer 1983; 51:47-52.
27. Sharkis SJ, Santos GW, Colvin M. Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroxyperoxycyclophosphamide (4HC). Blood 1980; 55:521-533.
28. Granger S, Janossy G, Francis E, Blackblock H. Elimination of T lymphocytes from human bone marrow with monoclonal T antibodies and cytolytic complement. Br J Haematol 1982; 50:367-374.
29. Philip T, Biron P, Herve P, et al. Massive therapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin’s malignant lymphoma with a very bad prognosis. Eur J Cancer 1983; 19:1371-1379.